Filing Flows › Steris (STE) › Q2 FY27 › vs Q1 FY27
Steris (STE) Q2 FY27 vs Q1 FY27 (quarter over quarter)
Steris's revenue rose $95.9M (+6%) from $1.5B in Q1 FY27 to $1.6B in Q2 FY27. The biggest changes: Healthcare +$74.1M (+7%); Life Sciences: +$23.9M (+16%); AST −$2.0M (-0.7%). Gross margin 44.7% against 45.8% (-1.1 pts).
Steris, Q2 FY27: revenue $1.6B (+9% year over year), operating margin 18.5%, net earnings $214M, operating cash flow $289M. The chart draws each line against Q1 FY27, the increases inside each band.
Margins
| Q2 FY27 | Q1 FY27 | Change | |
|---|---|---|---|
| Gross margin | 44.7% | 45.8% | -1.1 pts |
| Operating margin | 18.5% | 19.1% | -0.6 pts |
| Net margin | 13.5% | 13.5% | +0.0 pts |
| Free cash flow margin | 13.4% | 18.7% | -5.3 pts |
Every line
| Line | Q2 FY27 | Q1 FY27 | Change | % |
|---|---|---|---|---|
| Healthcare | $1.1B | $1.0B | $74.1M | +7% |
| AST | $296M | $298M | −$2.0M | -0.7% |
| Life Sciences: | $171M | $147M | $23.9M | +16% |
| Revenue | $1.6B | $1.5B | $95.9M | +6% |
| Gross profit | $711M | $684M | $26.6M | +4% |
| Cost of revenue | $878M | $808M | $69.3M | +9% |
| Operating profit | $294M | $286M | $8.5M | +3% |
| Operating expenses | $416M | $398M | $18.1M | +5% |
| Pre-tax earnings | $288M | $274M | $14.5M | +5% |
| Other expense, net | $6.3M | $12.3M | −$6.0M | -49% |
| Research & development | $31.5M | $28.6M | $2.9M | +10% |
| SG&A | $366M | $370M | −$3.7M | -1% |
| Net earnings | $214M | $201M | $13.1M | +7% |
| Income tax | $73.9M | $72.5M | $1.4M | +2% |
| Depreciation & amortization | $126M | $124M | $1.8M | +1% |
| Share-based compensation | $21.7M | $12.8M | $8.9M | +70% |
| Working capital & other | $72.4M | −$29.5M | $102M | — |
| Operating cash flow | $289M | $367M | −$78.1M | -21% |
| Free cash flow (OCF − capex) | $213M | $280M | −$66.7M | -24% |
| Capital expenditures | $76.1M | $87.5M | −$11.4M | -13% |
Questions
How much did Steris's revenue grow quarter over quarter in Q2 FY27?
Steris's revenue rose $95.9M (+6%) from $1.5B in Q1 FY27 to $1.6B in Q2 FY27.
What drove Steris's revenue change in Q2 FY27?
Healthcare +$74.1M (+7%); Life Sciences: +$23.9M (+16%); AST −$2.0M (-0.7%).